Insider Buying: Phibro Animal Health Co. (NASDAQ:PAHC) Director Buys 5,000 Shares of Stock

Phibro Animal Health Co. (NASDAQ:PAHC) Director E Thomas Corcoran purchased 5,000 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were purchased at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the purchase, the director now owns 25,000 shares of the company’s stock, valued at $500,500. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Phibro Animal Health Trading Up 0.2 %

Shares of PAHC opened at $19.46 on Friday. Phibro Animal Health Co. has a twelve month low of $9.40 and a twelve month high of $22.31. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79. The firm has a market capitalization of $788.13 million, a P/E ratio of 60.81, a PEG ratio of 1.66 and a beta of 0.52. The firm’s 50-day moving average is $18.51 and its two-hundred day moving average is $16.28.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.47%. The ex-dividend date of this dividend is Wednesday, September 4th. Phibro Animal Health’s dividend payout ratio is currently 150.00%.

Analyst Ratings Changes

PAHC has been the topic of several recent analyst reports. Bank of America boosted their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. Barclays upped their price objective on Phibro Animal Health from $10.00 to $13.00 and gave the stock an “underweight” rating in a report on Friday, May 10th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $13.25.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds and other institutional investors have recently bought and sold shares of the company. CWM LLC grew its holdings in Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after purchasing an additional 1,035 shares during the last quarter. Fidelis Capital Partners LLC purchased a new stake in shares of Phibro Animal Health in the 1st quarter worth about $46,000. China Universal Asset Management Co. Ltd. grew its stake in Phibro Animal Health by 65.0% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock valued at $50,000 after acquiring an additional 1,531 shares during the last quarter. Quest Partners LLC acquired a new stake in Phibro Animal Health in the 4th quarter valued at about $56,000. Finally, Summit Securities Group LLC purchased a new position in Phibro Animal Health during the 2nd quarter valued at about $83,000. 99.34% of the stock is owned by institutional investors and hedge funds.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.